Cita APA (7a ed.)

Jimbu, L., Mesaros, O., Neaga, A., Nanut, A. M., Tomuleasa, C., Dima, D., . . . Zdrenghea, M. (2021). The Potential Advantage of Targeting Both PD-L1/PD-L2/PD-1 and IL-10–IL-10R Pathways in Acute Myeloid Leukemia. MDPI AG.

Cita Chicago Style (17a ed.)

Jimbu, Laura, Oana Mesaros, Alexandra Neaga, Ana Maria Nanut, Ciprian Tomuleasa, Delia Dima, Corina Bocsan, y Mihnea Zdrenghea. The Potential Advantage of Targeting Both PD-L1/PD-L2/PD-1 and IL-10–IL-10R Pathways in Acute Myeloid Leukemia. MDPI AG, 2021.

Cita MLA (8a ed.)

Jimbu, Laura, et al. The Potential Advantage of Targeting Both PD-L1/PD-L2/PD-1 and IL-10–IL-10R Pathways in Acute Myeloid Leukemia. MDPI AG, 2021.